Endovascular treatment as the main approach for Spetzler-Martin grade III brain arteriovenous malformations.
Humain Baharvahdat, Raphaël Blanc, Robert Fahed...
https://pubmed.ncbi.nlm.nih.gov/32989031Actively Recruiting
Age: 18Years +
All Genders
ID02879071
Long Term Follow-up After Embolization of Brain Arteriovenous Malformations
Led by Fondation Ophtalmologique Adolphe de Rothschild · Updated on 2026-01-22
1000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to collect standardized long-term data on patients who have undergone embolization for brain arteriovenous malformations, a condition where abnormal connections form between arteries and veins in the brain. The study addresses the lack of consistent follow-up protocols and limited reliable data available for these patients after their treatment. Participants will be observed over time without receiving any new treatment as part of the study. The focus is on monitoring the condition following embolization, with no intervention or comparison groups involved. Throughout the study, participants will undergo assessments including angiographic evaluations to measure the occlusion of the arteriovenous malformation five years after embolization. The research team will track these outcomes to better understand long-term results. Participation may last several years, allowing for extended follow-up and data collection.
CONDITIONS
Brief Title
Long Term Follow-up After Embolization of Brain Arteriovenous Malformations
Who Can Participate
Age: 18Years +
All Genders
Eligibility Criteria
You may qualify if you...
- Diagnosed with an arteriovenous malformation
- Age over 18 years old
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Long-term Monitoring
Duration - Up to 5 years after embolization
Participants are followed long term after their embolization procedure to monitor the status of their brain arteriovenous malformations.
1 to 2 visits depending on angiographic evaluation schedules
Trial Site Locations
Total: 1 location
1
Fondation Ophtalmologique Adolphe de Rothschild
Paris, France, 75019
Actively Recruiting
Loading map...
Research Team
A
Amélie Yavchitz, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Published Research Related To This Trial
Endovascular Treatment for Low-Grade (Spetzler-Martin I-II) Brain Arteriovenous Malformations.
H Baharvahdat, R Blanc, R Fahed...
https://pubmed.ncbi.nlm.nih.gov/30792251